Can Gray Hair Serums Really Restore Your Natural Hair Color? What Peptide and Postbiotic Claims Prove
At a glance
If you’re shopping for a gray-hair serum, you’ll see two different promises: slowing new grays and restoring color to hairs that are already gray. Those are very different outcomes. Peptide and postbiotic research makes the idea biologically plausible, but small human studies and supplier-reported results do not prove that a typical serum reliably repigments long-standing gray hair. The evidence depends on what was tested and what changed.
To understand what a serum could change about your hair, start with how pigment is made. Hair color comes from melanin produced by melanocytes in the hair follicle. As hair grays, pigment production becomes less reliable and can eventually stop. That biology makes “reactivating pigment” sound plausible—but it does not mean every gray hair is still biologically capable of returning to its original shade.
When you see “reverse gray hair,” watch for brands combining several different outcomes under one claim.
Your serum might be designed to preserve pigment-producing cells, slow the appearance of new gray strands, change melanogenesis markers in a laboratory model, or visibly repigment some hairs in people. Those are not interchangeable findings.
In this Briefing
- Why hair turns gray
- The four outcomes anti-gray products need to separate
- What Palmitoyl Tetrapeptide-20 actually shows
- What the Arey clinical study proves—and does not prove
- What postbiotic anti-gray claims show
- What the 2026 proteoglycan study adds
- What counts as real repigmentation?
- How to evaluate an anti-gray serum
Why does hair turn gray?
Your natural hair color depends on melanocytes in the follicle and stem-cell populations that help replenish pigment-producing cells. Melanogenesis involves pathways including the melanocortin-1 receptor, MITF, tyrosinase, oxidative stress, and other follicular signals.[1]
As your hair ages, pigment production can become less efficient, oxidative stress can increase, and the follicular pigment system can progressively lose function.
That progression matters when you’re choosing a serum: a partially functioning follicle is a different biological target from a follicle that no longer produces meaningful pigment. A serum may be more plausible as a way to preserve or support residual pigment activity than as a way to restore color to long-standing fully white hair.
What are the four different anti-gray outcomes?
| Claim | What it actually means | What evidence would support it |
|---|---|---|
| Preventing pigment loss | Helping maintain follicular pigment function before more color is lost. | Longitudinal human evidence showing less progression of graying than a suitable control. |
| Slowing new graying | Reducing the rate at which newly growing hairs emerge gray. | Controlled gray-hair counts over several months and across enough hair-growth cycles to show a difference from placebo. |
| Increasing melanogenesis markers | Changing laboratory or follicular markers linked to melanin production, such as MITF, MC1R, tyrosinase-related proteins, or melanin content. | Mechanistic studies. Useful for plausibility, but not proof of visible repigmentation by themselves. |
| Repigmenting previously gray hair | Restoring visible pigment to a hair or follicle that was previously producing gray or white hair. | Controlled photographic, instrumental, or blinded hair-count evidence showing the same previously gray hairs becoming visibly pigmented. |
When you see fewer grays reported after six months, don’t assume previously gray hairs regained color. A lower percentage could reflect fewer new grays, better retention of pigmented hairs, or true repigmentation. A study has to be designed carefully to tell those apart.
What does Palmitoyl Tetrapeptide-20 actually show?
If you see Palmitoyl Tetrapeptide-20 on a label, you’re looking at a biomimetic peptide designed to act as an agonist of alpha-melanocyte-stimulating hormone signaling.
To assess this peptide’s claims, look at what researchers actually tested: a 2018 study evaluated it in laboratory models, ex vivo hair follicles, and a small human study involving 15 men with premature graying. The peptide increased melanogenesis-related activity in laboratory and isolated-follicle tests, increased markers including MC1R, TRP-1, and Melan-A, and reduced intracellular hydrogen peroxide. After three months of daily application of a lotion containing 10 ppm of the peptide, investigators also measured protein-expression changes in plucked hairs.[2]
For your buying decision, that is useful mechanistic evidence. It shows that the peptide can influence pathways related to follicular pigmentation.
What it does not establish is that a retail serum containing Palmitoyl Tetrapeptide-20 will reliably restore your natural color to ordinary age-related gray hair. The human sample was very small, the study involved premature canities, and the key reported findings included biological markers rather than a large controlled trial of visible repigmentation.
You may also see a case report published in a 2022 journal issue (online in 2023) that described a 25-year-old woman with premature graying who used a topical Palmitoyl Tetrapeptide-20 formulation with oral biotin and calcium pantothenate supplements and showed substantial visible repigmentation over five months.[3] A single case cannot show whether the topical peptide, supplements, spontaneous change, or another factor caused the result.
What does the Arey study prove?
If you’re considering Arey’s regimen, note the study population: the brand reports a six-month randomized, double-blind, placebo-controlled study of 173 adults ages 28 to 65, all with less than 25% gray hair at baseline.
When you read Arey’s clinical summary, the company reports a 13% decrease in gray-hair growth with The System versus a 10% increase with placebo. Results were determined by blinded clinical counting and/or photo grading.[4]
For your comparison, that is stronger evidence than an uncontrolled before-and-after photo series.
Before you attribute this result to one serum, consider the complete regimen that was tested. Arey tests The System as a combined scalp-serum-and-oral-supplement regimen rather than as evidence for one isolated topical peptide. The company’s site also says the study has been accepted for publication, but until the full peer-reviewed methods and results are available, BB cannot independently assess all protocol details, exclusions, statistical analyses, and outcome definitions.
Most importantly, don’t confuse less new gray-hair growth with proof that hairs already growing gray regained pigment.
If you have fully white hairs, note that Arey itself states its system cannot return them to their original shade and frames its strongest use case around slowing progression and repigmenting hairs in earlier stages.[4]
What about postbiotic anti-gray ingredients?
You may also come across postbiotic technology as an emerging anti-gray approach.
One supplier ingredient you may encounter is Chemyunion’s BioTech4 AntiGray, which uses Lactobacillus Ferment Lysate and is marketed as a postbiotic active designed to support melanogenesis, melanocyte function, pigment distribution, and antioxidant protection.
When you see supplier claims for this ingredient, the reported figures include a 43% increase in melanin content in ex vivo human follicles and a 120-day clinical study using 3% active in 90 volunteers. According to Chemyunion, 76.7% of participants reported a reduction in gray hair and hair-color uniformity improved by 27%.[5]
Those results are worth understanding before you buy, but they are supplier-provided rather than independently published clinical evidence. The public summary does not establish that previously gray strands were individually tracked and shown to repigment.
For your buying decision, that means BioTech4 AntiGray currently supports a promising ingredient-level anti-gray claim, not a category-wide conclusion that postbiotics reverse gray hair.
What does the 2026 proteoglycan study add?
You may also see newer proteoglycan claims. A 2026 laboratory study evaluated a topical formulation called PP-PTKL in human melanocytes and other cell models.
What did the study measure? Under experimentally suppressed Wnt/beta-catenin signaling, the formulation increased MITF expression in a dose-dependent manner. It also showed antioxidant and anti-inflammatory activity in laboratory assays.[6]
Why is MITF relevant to your serum choice? It helps regulate melanocyte function and melanogenesis.
Before you treat the result as color restoration, remember this study did not test whether people developed fewer gray hairs or whether previously gray hairs regained visible pigment. Three of the four authors were affiliated with the product developer’s research and development department.
For your decision, this is why increasing a melanogenesis marker is not the same as repigmenting gray hair.
What counts as convincing repigmentation evidence?
If a serum promises to restore your hair color, look for studies that follow the same follicles or clearly identified hairs over time and show that previously gray or white hairs began producing visible pigment after treatment.
When you read a study, look for these features:
- a randomized controlled design;
- blinded hair counts or image analysis;
- enough follow-up to cover several months of hair growth;
- clear separation between prevention of new grays and repigmentation of existing gray hairs;
- documentation of baseline percentage of gray hair;
- testing of the exact finished product you can buy;
- results that are not dependent on simultaneous supplements or hair color products.
A laboratory rise in melanin, MITF, MC1R, or tyrosinase-related proteins makes a technology more biologically plausible. It does not tell you how many of your gray hairs will actually change color.
How should you evaluate a gray-hair serum?
- Look for the exact outcome. Does the brand claim prevention, slower progression, pigment support, or visible repigmentation?
- Check whether the finished product was tested. Supplier data on one raw material do not automatically validate every serum containing it.
- Look for a control group. Gray hair changes slowly, so uncontrolled before-and-after images are especially difficult to interpret.
- Check the starting population. Evidence in premature graying or people with less than 25% gray hair may not apply to someone with extensive long-standing white hair.
- Separate topical and oral products. If the study uses a serum plus a supplement, it does not prove the serum works independently.
- Be skeptical of “reactivates dormant pigment” unless the brand shows direct human evidence. A pathway story is not the same as a visible result.
- Expect months, not days. Any credible pigmentation change has to appear as new hair grows.
If you want to evaluate a claim such as “clinically proven,” see BB’s Briefing on cosmetic marketing claims.
The BB Perspective
If you’re following gray-hair research, repigmentation is no longer a purely speculative beauty claim. Palmitoyl Tetrapeptide-20 has mechanistic and small human data, Arey reports a sizable controlled regimen study, and newer postbiotic and proteoglycan approaches are targeting the same biology from different directions.
Your expectations should still reflect that the category is ahead of its strongest evidence.
For your decision, the key distinction is whether a product preserves pigment, slows new graying, changes a melanogenesis marker, or visibly repigments hair that was already gray. A brand should not use evidence for one outcome to imply another.
If you are considering an anti-gray serum, give the most weight to controlled human testing on the exact finished product and to clearly defined gray-hair counts over several months. Treat laboratory pigment markers and supplier studies as supporting evidence—not as proof that your natural color will return.
Last reviewed: October 2026
Sources
Paus R, Sevilla A, Grichnik JM. Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers. Journal of Investigative Dermatology. 2024;144(3):474–491. doi:10.1016/j.jid.2023.09.276.
This hair-follicle-specific review explains how oxidative damage, melanocyte function, pigment-producing cells, and melanocyte stem cells contribute to graying. It distinguishes potentially reversible pigment loss from later stem-cell depletion. It describes biological possibilities, not a clinical test of any anti-gray retail serum. The lead author disclosed commercial interests in developing and testing anti-graying agents through CUTANEON and Monasterium Laboratory; another author disclosed industry consulting relationships. Return to citation.
Almeida Scalvino S, Chapelle A, Hajem N, et al. Efficacy of an agonist of α-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation. International Journal of Cosmetic Science. 2018;40(5):516–524. doi:10.1111/ics.12494.
Laboratory and isolated-follicle tests were combined with plucked-hair analyses in 15 men with premature graying after three months of a lotion containing 10 ppm of the peptide. Pigment-related markers changed, but visible repigmentation from ordinary anti-gray retail serums was not proven. Several authors were affiliated with cosmetic ingredient suppliers and industry research organizations, including IFF-Lucas Meyer Cosmetics and Alès Groupe. Return to citation.
Chavan D. Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%). International Journal of Trichology. 2022;14(6):207–209. Published online January 31, 2023. doi:10.4103/ijt.ijt_85_22.
This single case followed a 25-year-old woman using a Palmitoyl Tetrapeptide-20 topical solution plus oral biotin and calcium pantothenate. The reported visible repigmentation occurred over months, without a comparison group or a way to isolate the topical peptide’s contribution. Return to citation.
Arey. Clinical Studies. Accessed October 2026.
Arey reports a six-month randomized, double-blind, placebo-controlled study of The System in 173 adults with less than 25% gray hair. The company reports a 13% decrease in gray-hair growth versus a 10% increase with placebo. The public page is a company summary; the full peer-reviewed report was not yet available to BB for independent assessment at this review. Return to citation.
Chemyunion. BioTech4 AntiGray: a postbiotic active that acts at the root of hair graying. 2026.
The supplier describes BioTech4 AntiGray as Lactobacillus Ferment Lysate and reports ex vivo melanin findings plus a 120-day clinical study in 90 volunteers. These are supplier-provided results and are used as emerging ingredient evidence rather than independent proof that postbiotic products reverse gray hair. Return to citation.
Vega Diez D, Arias EM, Floriach N, Bravo E. A proteoglycan-based topical treatment for hair greying: in vitro antioxidant and pro-melanogenic effects. Frontiers in Medicine. 2025;12:1734454. Published online January 14, 2026. doi:10.3389/fmed.2025.1734454.
Cell-model experiments found higher MITF expression and antioxidant and anti-inflammatory activity. The study did not test whether people developed fewer gray hairs or visibly repigmented existing gray hairs. Three of four authors worked in Laboratorio Genové’s R&D department. The paper also disclosed financial support, including one-time remuneration to the first author for scientific supervision, quality review, and publication oversight. Return to citation.